- Ultragenyx Pharmaceutical Inc at Cowen Health Care Conference- Orphan CNS Panel Discussion TranscriptMar 07, 2023
- AVROBIO Inc Virtual Gaucher Disease Program Update TranscriptDec 07, 2022
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- AVROBIO Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- AVROBIO Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVROBIO Inc and Annexon Inc in the Orphan CNS Panel at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- AVROBIO Inc Cystinosis Update Call TranscriptFeb 09, 2022
- AVROBIO Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- AVROBIO Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- AVROBIO Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 17, 2021
- AVROBIO Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- AVROBIO Inc Presents new Clinical Data from Fabry Disease, Cystinosis and Gaucher disease Type 1 Programs TranscriptFeb 08, 2021
- AVROBIO Inc at ICR Virtual Conference TranscriptJan 14, 2021
- AVROBIO Inc Virtual R&D Day TranscriptNov 17, 2020
- AVROBIO Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 13, 2020
- AVROBIO Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Avrobio Inc at WORLDSymposium 2020 TranscriptFeb 11, 2020
- AVROBIO Inc Announces Positive Data from Clinical Trials of AVR-RD-01- Call TranscriptJul 15, 2019
Avrobio Inc at WORLDSymposium 2020 Transcript
Hello, everybody. I'd like to welcome you to those who are attending in person as well as those up north listening to us via webcast, and thank you for attending the AVROBIO Investor Update down here in Orlando associated with the WORLDSymposium.
My name is Geoff MacKay, the President and CEO of AVROBIO. Joining me tonight is the President of R&D, Dr. Birgitte Volck; Dr. Chris Mason, our Chief Science Officer; and Erik Ostrowski, our Chief Financial Officer.
We're on the verge of our fifth anniversary as a company. And tonight, we actually do have a substantial amount of data to share, including some first-ever seen data in gene therapy.
So before I begin, I'd just highlight that this presentation and our discussion today will contain forward-looking statements based on our current expectation and beliefs of future events as of today. Statements are subject to a number of risks and uncertainties, including those risk factors from our latest 10-Q, that could cause results to differ materially and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)